Copyright © 2000 by the European Society of Cardiology.
Letters to the Editor
Digoxin and morality in idiopathic dilated cardiomyopathy
Service de Cardiologie B et Laboratoire d'électrophysiologie cardiaque, Centre Hospitalier Universitaire Trousseau, Tours, France
References
- N Engl J Med. 1997;336:525533
[Abstract/Free Full Text] - Lindsay SJ, Kearney MT, Prescott RJ, Fox KAA, Nolan J. Digoxin and mortality in chronic heart failure. Lancet. 1999;354:10039183[Web of Science][Medline]
- Spargias KS, Hall AS, Ball SH. Safety concerns about digoxin after acute myocardial infarction. Lancet. 1999;354:391392[CrossRef][Web of Science][Medline]
- Nolan J, Batin PD, Andrews R. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98:15101516
[Abstract/Free Full Text] - Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1999;33:12031207
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||